TKI258

· Novartis

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TKI258, covering 2009-11-23 to 2021-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety of TKI258 in Advanced/Metastatic Melanoma Subjects [Phase 1, Phase 2]